| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Additional Value of Whole-Body Fluorodeoxyglucose Positron Emission Tomography in the Detection of Distant Metastases of Non–Small-Cell Lung Cancer
|
Stroobants, Sigrid G.
|
|
2003
|
4 |
Supplement 1 |
p. 242-247
6 p.
|
artikel
|
| 2 |
A Multicenter Phase II Study of Gemcitabine and Oxaliplatin for Malignant Pleural Mesothelioma
|
Schuette, Wolfgang
|
|
2003
|
4 |
Supplement 1 |
p. 294-297
4 p.
|
artikel
|
| 3 |
Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management
|
Herbst, Roy S.
|
|
2003
|
4 |
Supplement 1 |
p. 366-369
4 p.
|
artikel
|
| 4 |
Diagnostic Imaging and Other Tools in the Detection of Lung Cancer
|
Luketich, James D.
|
|
2003
|
4 |
Supplement 1 |
p. 248-
1 p.
|
artikel
|
| 5 |
Docetaxel Versus Docetaxel/Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Analysis of a Multicenter, Randomized Phase III Study
|
Georgoulias, V.
|
|
2003
|
4 |
Supplement 1 |
p. 288-293
6 p.
|
artikel
|
| 6 |
Gefitinib in the Treatment of Advanced, Refractory Non–Small-Cell Lung Cancer: Results in 124 Patients
|
Hainsworth, John D.
|
|
2003
|
4 |
Supplement 1 |
p. 347-355
9 p.
|
artikel
|
| 7 |
Gemcitabine and Carboplatin Regimens in Advanced Non–Small-Cell Lung Cancer: Focus on Randomized Phase III Trials
|
Edelman, Martin J.
|
|
2003
|
4 |
Supplement 1 |
p. S40-S44
5 p.
|
artikel
|
| 8 |
2002 Highlights From: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; Frankfurt, Germany November 19–22, 2002
|
Hightower, Mary
|
|
2003
|
4 |
Supplement 1 |
p. 333-335
3 p.
|
artikel
|
| 9 |
Irinotecan/Taxane Combinations in Advanced Non–Small-Cell Lung Cancer
|
Langer, Corey J.
|
|
2002
|
4 |
Supplement 1 |
p. S10-S14
5 p.
|
artikel
|
| 10 |
Molecularly Targeted Chemoprevention of Lung Cancer
|
Gibson, Angelia D.
|
|
2003
|
4 |
Supplement 1 |
p. 269-272
4 p.
|
artikel
|
| 11 |
Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer
|
Latreille, Jean
|
|
2003
|
4 |
Supplement 1 |
p. 231-236
6 p.
|
artikel
|
| 12 |
Phase II Study of Docetaxel/Vinorelbine in Patients with non—small-Cell-Lung Cancer Previously Treated with Platinum-Based Chemotherapy
|
Muñoz, Alberto
|
|
2002
|
4 |
Supplement 1 |
p. 168-173
6 p.
|
artikel
|
| 13 |
Phase I Study of Sequential Deoxyazacytidine/Depsipeptide Infusion in Patients with Malignancies Involving Lungs or Pleura
|
Schrump, David S.
|
|
2002
|
4 |
Supplement 1 |
p. 186-192
7 p.
|
artikel
|
| 14 |
The Emerging Role of Gemcitabine in Combination with Radiation in Locally Advanced, Unresectable Non–Small-Cell Lung Cancer
|
Langer, Corey J.
|
|
2003
|
4 |
Supplement 1 |
p. S45-S49
5 p.
|
artikel
|
| 15 |
The Role of Irinotecan Combined with Cisplatin or Carboplatin in the Treatment of Advanced Non—Small-Cell Lung Cancer
|
Bunn Jr, Paul A.
|
|
2002
|
4 |
Supplement 1 |
p. S5-S9
5 p.
|
artikel
|
| 16 |
Unfavorable Therapeutic Index of Cisplatin/Gemcitabine/Vinorelbine in Advanced non—small-Cell Lung Cancer
|
Hesketh, Paul J.
|
|
2002
|
4 |
Supplement 1 |
p. 47-51
5 p.
|
artikel
|
Tijdschrift beschrijving